Hochhaus, A; Lin, F; Reiter, A; Skladny, H; Shepherd, PCA; Sill, H; Allan, NC; Hehlmann, R; Goldman, JM; Cross, NCP.
Levels of minimal residual disease in chronic myelogenous leukemia (CML) patients in complete cytogenetic remission after interferon-alpha-therapy correlate with risk of relapse.
EXP HEMATOL 1996 24: 579-579.
Web of Science